Benzodiazepines revisited

British Journal of Medical Practitioners

Volumn 5, Issue 1, 2012, Pages

  Mehdi, Tauseef ^a  

^a WEST LONDON MENTAL HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM; FLURAZEPAM; GLUTETHIMIDE; LORAZEPAM; MEPROBAMATE; MIDAZOLAM; NITRAZEPAM; OXAZEPAM; TEMAZEPAM; TRIAZOLAM;

ALCOHOL WITHDRAWAL; ALCOHOLISM; AMNESIA; ANESTHESIA INDUCTION; ANTICONVULSANT ACTIVITY; ANXIETY DISORDER; ARTICLE; ATAXIA; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPTIC STATE; FALLING; GENERAL PRACTICE; HUMAN; INSOMNIA; MUSCLE RELAXATION; MUSCLE SPASM; MYOCLONUS EPILEPSY; NEUROTRANSMISSION; NONHUMAN; PATIENT CARE; PHYSICIAN ATTITUDE; PRESCRIPTION; SEDATION; SIDE EFFECT; SPASTICITY; THROMBOPHLEBITIS; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANQUILIZING ACTIVITY; TREATMENT DURATION; UNITED KINGDOM; WITHDRAWAL SYNDROME;

EID: 84860639751     PISSN: 17578515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry 2005; 18:249-255.
2. Ashton, C H: All Party Action Group on Tranquilliser addiction. London: House of Commons, November 7, 2006
3. Tyrer P. Dependence on benzodiazepines. Brit J Psychiat. 1980; 137: 576-577.
4. Lader M. Benzodiazepines-the opium of the masses. Neuroscience 1978;3:159-165.
5. Pevnick JS, Jasinski DR, Haertzen CA. Abrupt withdrawal from therapeutically administered diazepam. Arch Gen Psychiatry. 1978; 35:995-8.
6. Winokur A, Rickels K, Greenblatt DJ, Snyder PJ, Schatz NJ. Withdrawal reaction from long term, low dosage, administration of diazepam. Arch Gen Psychiatry 1980; 37:101-5.
7. Tyrer P, Rutherford D, Huggett T. Benzodiazepine withdrawal symptoms and propranolol. Lancet 1981; 1: 520-2.
8. Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. Br Med J 1981; 283:643-5.
9. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after chronic therapy. Lancet 1983; 1: 1402-6.
10. Committee on Safety of Medicines. Benzodiazepines, dependence and withdrawal symptoms. 1988; Current Problems 21
11. British National Formulary. 2009: British Medical Association/Royal Pharmaceutical Society of Great Britain. BMJ Publishing Group & RPS Publishing
12. Drug and Therapeutics Bulletin. Withdrawing patients from antidepressants. Drug and Therapeutics Bulletin, 1999; 37 (July), 49-52.
13. Anderson, I. M., Nutt, D. J. & Deakin J. F. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology, 2000; 14, 3-20.
14. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. World Health Organization
15. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders(4th edn) (DSM-IV). APA
16. Polc P, Mohler H, Haefely W. The effects of diazepam on spinal cord activities: possible sites and mechanisms of action. NS Arch Pharmacol 1988;34: 124-128.
17. Polc P, Haefely W. Effects of two benzodiazepines, phenobarbitone and baclofen on synaptic transmission in the cat cuneate nucleus. Naunyn Schmiedebergs Arch Pharmacol. 1976;294(2):121-131.
18. Wolf P, Haas HL. Effects of diazepines and barbiturates on hippocampal recurrent inhibition. NS Arch Pharmacol 1977; 299: 211-218.
19. Raab W, Gummit RJ. Anticonvulsant action of diazepam: Increase of cortical post-synaptic inhibition. Epilepsia 1977; 18:117-120.
20. Cook, L & Davidson, A. B. In The Benzodiazepines (eds S. Garattini, E. Mussini, L 0.Randall). New York: Raven Press, 1973; pp 327-45.
21. Dantzer, R. Behavioural effects of benzodiazepines: a review. Biobehavioural Reviews, 1977;1,71-86.
22. Haefely, W.E. Behavioural and neuropharmacological aspects of drugs used in anxiety and related states. In Psychopharmacology: A Generation of Progress (eds M. A. Upton, A. Di Mascio, K. F. Killam). New York: Raven Press, 1978; pp 1359-74.
23. Cooper SJ. Benzodiazepines, barbiturates and drinking, In: Cooper SJ ed. Theory in psychopharmacology. London: Academic Press 1983; 2:115-148.
24. Raabe, W. & Gumnit, R. J. Anticonvulsant action of diazepam: increase of cortical postsynaptic inhibition. Epilepsia, 1977; 18, 11720
25. Haefely, W.E. Central Actions of Benzodiazepines: General Introduction. Brit.J.Psychiat, 1978; 133,231-238.
26. Wheatley, D. Effects of drugs on sleep. In Psychopharmacology of sleep. Wheatley D, ed. New York: Raven Press, 1981; 153-176.
27. Lader, M. The present status of benzodiazepines and psychiatry and medicine. Drug Res 1980; 30:910-913.
28. Rickels, K. Use of anti-anxiety drugs and anxious outpatients. Psychopharmacology 1978; 58:1-17.
29. Greenblatt, D.J & Shader RI: Benzodiazepines in Clinical Practice. New York, Raven Press, 1974
30. Gestaut H, Naquet R, Poire R, et al: Treatment of status-epilepticus with diazepam (Valium). Epilepsia 1965; 6:167-182.
31. Lombroso CT: Treatment of status epilepticus with diazepam. Neurology 1966; 16:629-634.
32. Prensky AL, Roff MC, Moore MJ, et al: Intravenous diazepam in the treatment of prolonged seizure activity. N Engl J Med 1967; 276:779-784.
33. Delgado-Escueta AV, Westertain C, Treiman DM, et al: Current concepts in neurology: management of status epilepticus. N Engl J Med 1982; 306:1337-1340.
34. Leppick IE, Derivian AT, Homan RW, Walker J, Ramsay E and Patrick B. Double blind study of lorazepam and diazepam in status epilepticus. J. Am. Med. Assoc. 249, 1452-4.
35. Walker JE, Homan RW, Vasko MR, et al: Lorazepam in status epilepticus. Ann Neurol 1979; 6:207-213.
36. Griffith PA, Karp HR: Lorazepam in therapy for status epilepticus. Ann Neurol. 1980; 7:493
37. Gestaut H, Coujon J, Poire R et al: Treatment of status epilepticus with a new benzodiazepine more active than diazepam. Epilepsia 1971; 12:197-214.
38. Eadie MJ. Anti-convulsant drugs: an update. Drugs 1984; 27, 328-63.
39. Robertson MM. Current status of the 1,4-and 1,5-benzodiazepines in the treatment of epilepsy: the place of clobazam. Epilepsia 1986; 27 (Suppl. 1), 27-41.
40. Guengerich FP (January 2008). Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol. 2008; 21 (1): 70-83.
41. Whitwam JG, Al-Khudhairi D, McCloy RF. Comparison of midazolam and diazepam in doses of comparable potency during gastroscopy. Br J Anaesth 1983; 55:773-777.
42. Adam Noble, Ian Martin and David Nutt: Calming the Brain. 1st Edition. UK. Martin Dunitz, Taylor and Francis Group, 2004; 135
43. I. Hindmarch, G. Beaumont, S. Brandon, B.E. Leanord: Benzodiazepines:Current Concepts. 1st Edition. Sussex, England. John Wiley and Sons Ltd. 1990; 66-77.
44. CMO's Update 37. Benzodiazepines warning. Department of Health; January 2004. p. 4
45. National Service Framework for Mental Health. London: Department of Health; 1999. Available from: www.dh.gov.uk
46. H Aston: Benzodiazepines: How they work and how to withdraw aka "The Ashton Manual". 2002; Ch 3 Table1. http://www.benzo.org.uk/manual/bzcha03.htm
47. Heather N, Bowie A, Ashton H, et al. Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addict Res Theory 2004; 12:141-154.
48. Cormack MA, Sweeney KG, Hughes-Jones H, et al. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br J Gen Pract 1994; 44:5-8.
49. http://www.cks.nhs.uk/benzodiazepine_and_z_drug_withdrawal/management/scenario_benzodiazepine_and_z_drug_withdrawal/managing_someone_who_wants_to_stop
50. Ashton H. Benzodiazepine dependence. In: Haddad P, Dursun S, Deakin B, editors. Adverse syndromes and psychiatric drugs. 2004